Related Experiment Video
Updated: Jun 25, 2026
04:01
Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Control by pulse parameters of DNA electrotransfer into solid tumors in mice
1Department of Experimental Oncology, Institute of Oncology, Ljubljana, Slovenia.
Gene Therapy
|February 13, 2009
Summary
Electrotransfer (electroporation) offers a promising alternative to viral vectors for in vivo gene delivery. Optimized pulse combinations can achieve high reporter gene expression in tumors, comparable to standard electro-gene therapy.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Gene Therapy
Background:
- Electrotransfer (electroporation) is a leading non-viral method for in vivo gene delivery.
- Optimizing electrotransfer protocols is crucial for therapeutic applications.
Purpose of the Study:
- To evaluate transfection efficiency using various high-field (HV) and low-field (LV) electrotransfer pulse combinations.
- To compare these protocols against a standard electro-gene therapy (EGT) protocol in murine tumors.
Main Methods:
- Reporter gene expression (GFP, luciferase) was measured in murine subcutaneous tumors.
- Diverse combinations of HV and LV pulses were tested and compared to EGT.
- Gene expression was quantified via fluorescence microscopy, flow cytometry, and luminometry.
Main Results:
- The standard EGT protocol (8 pulses, 600 V/cm, 5 ms) yielded the highest reporter gene expression.
- Optimized combinations of HV and LV pulses achieved comparable transfection efficiency to EGT.
- Higher gene expression was observed in B16 melanoma compared to SA-1 fibrosarcoma tumors.
Conclusions:
- Both electropermeabilization and electrophoresis are critical for effective electrotransfer.
- Simultaneous occurrence of electropermeabilization and electrophoresis is necessary for significant gene expression.
- Optimized electrotransfer protocols show potential for therapeutic gene delivery in tumors.
